Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners



Status:Suspended
Conditions:Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Women's Studies
Therapuetic Areas:Oncology, Reproductive
Healthy:No
Age Range:18 - Any
Updated:4/5/2019
Start Date:December 6, 2017
End Date:May 2019

Use our guide to learn which trials are right for you!

Couple-Focused ACT Intervention for Couples Coping With Cancer: A Pilot Study

This pilot clinical trial studies how well acceptance and commitment therapy works in
improving well-being in patients with stage III-IV cancer and their partners. Learning how to
accept negative thoughts and feelings and how to live in the present without worrying about
the future or past may improve coping skills in patients with stage III-IV cancer and their
partners.

PRIMARY OBJECTIVES:

I. To examine the feasibility and acceptability of couples' acceptance and commitment therapy
(ACT) (C-ACT).

II. To collect pilot data on the impact of C-ACT on patients' and partners' anxiety,
depression, and quality of life.

OUTLINE:

Patients and their partners attend 6 weekly ACT sessions over 60-75 minutes. Couples learn
skills of acceptance, avoidance, awareness, values and committed action, mindfulness and
values in relationships, and handling persistent worries and concerns. Patients and their
partners also do homework assignment after each session.

After completion of the study, patients and their partners are followed up at 1 week.

Inclusion Criteria:

- Diagnosed with stage 3 or 4 breast, cervical, colorectal, endometrial, hepatobiliary,
lung, melanoma, gynecological, prostate cancer in the past six months

- Married or cohabiting with a significant other of either gender for more than one year

- At the time of recruitment, a life expectancy of greater than 6 months and/or a
Karnofsky performance status of 80 or above or an Eastern Cooperative Oncology Group
(ECOG) score of 0 or 1

- English speaking

- No significant hearing impairment that would prevent participation in sessions

- Live within a 1 hour commuting distance from Rutgers Cancer Institute of New Jersey

Exclusion Criteria:

- Partner cannot have cancer diagnosis (other than non-melanoma skin cancer) and be
currently receiving treatment
We found this trial at
1
site
New Brunswick, New Jersey 08903
Principal Investigator: Sharon Manne
Phone: 732-235-6759
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials